Investing success and new assays
After a volatile start to 2021, the share price of last year’s top AIM performer received a boost on news of the launch of a new portfolio of assays. Elsewhere there were decent results from a software group and an exceptional investment gain from a private equity investor.
Draper Esprit: another big investment success
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Draper Esprit PLC
Venture Capital Play | Brain Health Contracts
A venture capital group covered here is raising new funds to take advantage of the buoyant…
Investing success and new assays
After a volatile start to 2021, the share price of last year’s top AIM performer received…
More on IDOX
Delightful reporting | AI attributes | Puzzling business
Our review here includes our thoughts on the latest update from a popular developer of video…
Animal spirits
We offer our usual forthright opinion on trading updates from two companies in the animal health…
More on Novacyt SA
A refocused business delivers
Having survived a near death experience several years ago, a manufacturer of specialist industrial equipment covered…
Better than expected
Some welcome good news at last for shareholders in this provider of online competitions to win…
More on SEC SpA
Investing success and new assays
After a volatile start to 2021, the share price of last year’s top AIM performer received…
